In this regard, the assessment of CRP levels (not included in the definition of SIRS) might be of additive value and may contribute to identifying those patients with an actual systemic inflammatory involvement who are at higher risk of worse clinical outcomes. This evidence concerns the gene CRP and systemic inflammatory response syndrome.